(VIANEWS) – The NYSE ended the session with Teva Pharmaceutical jumping 4.85% to $7.89 on Friday, after two consecutive sessions in a row of losses. NYSE rose 1.03% to $14,636.76, after three consecutive sessions in a row of losses, on what was an all-around bullish trend exchanging session today.
Today’s last reported volume for Teva Pharmaceutical is 9573740, 4.23% below its average volume of 9996720.
Teva Pharmaceutical’s last close was $7.52, 28.38% below its 52-week high of $10.50.
Teva Pharmaceutical’s Sales
Teva Pharmaceutical’s sales growth is a negative 3.7% for the present quarter and a decline by 1.6% for the next.
Teva Pharmaceutical’s Revenue
Year-on-year quarterly revenue growth declined by 7.9%, now sitting on 15.88B for the twelve trailing months.
Teva Pharmaceutical’s Stock Yearly Top and Bottom Value
Teva Pharmaceutical’s stock is valued at $7.89 at 19:18 EST, way under its 52-week high of $10.50 and higher than its 52-week low of $7.23.
Teva Pharmaceutical’s Moving Average
Teva Pharmaceutical’s worth is under its 50-day moving average of $8.57 and under its 200-day moving average of $8.75.
More news about Teva Pharmaceutical (TEVA).